15
Views
98
CrossRef citations to date
0
Altmetric
Transcriptional Regulation

Modulation of Transcriptional Activation and Coactivator Interaction by a Splicing Variation in the F Domain of Nuclear Receptor Hepatocyte Nuclear Factor 4α1

, , , &
Pages 6509-6522 | Received 24 Nov 1998, Accepted 25 Jun 1999, Published online: 28 Mar 2023

REFERENCES

  • Allan, G. F., X. Leng, S. Y. Tsai, N. L. Weigel, D. P. Edwards, M. J. Tsai, and J. O’Malley 1992. Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation. J. Biol. Chem. 267:19513–19520.
  • Ausubel F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, K. Struhl 1990. Current protocols in molecular biology. John Wiley & Sons, New York, N.Y.
  • Brzozowski, A. M., A. C. W. Pike, Z. Dauter, R. E. Hubbard, T. Bonn, O. Engstrom, L. Ohman, G. L. Greene, J. Gustafsson, and J. Carlquist 1997. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389:753–758.
  • Bulman, M. P., M. J. Dronsfield, T. Frayling, M. Appleton, S. C. Bain, S. Ellard, and J. Hattersley 1997. A missense mutation in the hepatocyte nuclear factor 4 alpha gene in a UK pedigree with maturity-onset diabetes of the young. Diabetologia 40:859–862.
  • Chakravarti, D., V. J. LaMorte, M. C. Nelson, T. Nakajima, I. G. Schulman, H. Juguilon, M. Montminy, and J. Evans 1996. Role of CBP/P300 in nuclear receptor signalling. Nature 383:99–103.
  • Chartier, F. L., J.-P. Bossu, V. Laudet, J.-C. Fruchart, and J. Laine 1994. Cloning and sequencing of cDNAs encoding the human hepatocyte nuclear factor 4 indicate the presence of two isoforms in human liver. Gene 147:269–272.
  • Chen, W. S., K. Manova, D. C. Weinstein, S. A. Duncan, A. S. Plump, V. R. Prezioso, R. F. Bachvarova, J. E. Darnell Jr.. 1994. Disruption of the HNF-4 gene, expressed in visceral endoderm, leads to cell death in embryonic ectoderm and impaired gastrulation of mouse embryos. Genes Dev. 8:2466–2477.
  • Committee, Nuclear Receptor Nomenclature. 1999. A unified nomenclature system for the nuclear receptor superfamily. Cell 97:161–163.
  • Dell, H., and J. Hadzopoulou-Cladaras 1999. CREB-binding protein is a transcriptional coactivator for hepatocyte nuclear factor-4 and enhances apolipoprotein gene expression. J. Biol. Chem. 274:9013–9021.
  • Ding, X. F., C. M. Anderson, H. Ma, H. Hong, R. M. Uht, P. J. Kushner, and J. Stallcup 1998. Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities. Mol. Endocrinol. 12:302–313.
  • Drewes, T., S. Senkel, B. Holewa, and J. Ryffel 1996. Human hepatocyte nuclear factor 4 isoforms are encoded by distinct and differentially expressed genes. Mol. Cell. Biol. 16:925–931.
  • Eckner, R., M. E. Ewen, D. Newsome, M. Gerdes, J. A. DeCaprio, J. B. Lawrence, and J. Livingston 1994. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev. 8:869–884.
  • Escriva, H., R. Safi, C. Hanni, M. C. Langlois, L. P. Saumitou, D. Stehelin, A. Capron, R. Pierce, and J. Laudet 1997. Ligand binding was acquired during evolution of nuclear receptors. Proc. Natl. Acad. Sci. USA 94:6803–6808.
  • Feng, W., R. C. Ribeiro, R. L. Wagner, H. Nguyen, J. W. Apriletti, R. J. Fletterick, J. D. Baxter, P. J. Kushner, and J. West 1998. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science 280:1747–1749.
  • Ferguson, A. T., and J. Davidson 1997. Regulation of estrogen receptor alpha function in breast cancer. Crit. Rev. Oncog. 8:29–46.
  • Fuernkranz, H. A., Y. Wang, S. K. Karathanasis, and J. Mak 1994. Transcriptional regulation of the apoAI gene by hepatic nuclear factor 4 in yeast. Nucleic Acids Res. 22:5665–5671.
  • Fuller, P. J. 1991. The steroid receptor superfamily: mechanisms of diversity. FASEB J. 5:3092–3099.
  • Furuta, H., N. Iwasaki, N. Oda, Y. Hinokio, Y. Horikawa, K. Yamagata, N. Yano, J. Sugahiro, M. Ogata, H. Ohgawara, Y. Omori, Y. Iwamoto, and J. Bell 1997. Organization and partial sequence of the hepatocyte nuclear factor-4 alpha/MODY1 gene and identification of a missense mutation, R127W, in a Japanese family with MODY. Diabetes 46:1652–1657.
  • Garcia, A. D., P. Ostapchuk, and J. Hearing 1993. Functional interaction of nuclear factors EF-C, HNF-4, and RXRα with hepatitis B virus enhancer I. J. Virol. 67:3940–3950.
  • Genetics Computer Group. 1994. Program manual for the Wisconsin Package, version 8. Genetics Computer Group Madison, Wis.
  • Giangrande, P. H., G. Pollio, and J. McDonnell 1997. Mapping and characterization of the functional domains responsible for the differential activity of the A and B isoforms of the human progesterone receptor. J. Biol. Chem. 272:32889–32900.
  • Green, V. J., E. Kokkotou, and J. Ladias 1998. Critical structural elements and multitarget protein interactions of the transcriptional activator AF-1 of hepatocyte nuclear factor 4. J. Biol. Chem. 273:29950–29957.
  • Gronemeyer, H., and J. Laudet 1995. Transcription factors 3: nuclear receptors. Protein Profile 2:1173–1308.
  • Guo, W., M. Chen, T. S. B. Yen, and J. Ou 1993. Hepatocyte-specific expression of the hepatitis B virus core promoter depends on both positive and negative regulation. Mol. Cell. Biol. 13:443–448.
  • Hadzopoulou-Cladaras, M., E. Kistanova, C. Evagelopoulou, S. Zeng, C. Cladaras, and J. Ladias 1997. Functional domains of the nuclear receptor hepatocyte nuclear factor 4. J. Biol. Chem. 272:539–550.
  • Halachmi, S., E. Marden, G. Martin, H. MacKay, C. Abbondanza, and J. Brown 1994. Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 264:1455–1458.
  • Hani, E. H., L. Suaud, P. Boutin, J. C. Chevre, E. Durand, A. Philippi, F. Demenais, N. Vionnet, H. Furuta, G. Velho, G. I. Bell, B. Laine, and J. Froguel 1998. A missense mutation in hepatocyte nuclear factor-4 alpha, resulting in a reduced transactivation activity, in human late-onset non-insulin-dependent diabetes mellitus. J. Clin. Investig. 101:521–526.
  • Hanstein, B., R. Eckner, J. DiRenzo, S. Halachmi, H. Liu, B. Searcy, R. Kurokawa, and J. Brown 1996. p300 is a component of an estrogen receptor coactivator complex. Proc. Natl. Acad. Sci. USA 93:11540–11545.
  • Hata, S., T. Inoue, K. Kosuga, T. Nakashima, T. Tsukamoto, and J. Osumi 1995. Identification of two splice isoforms of mRNA for mouse hepatocyte nuclear factor 4 (HNF-4). Biochim. Biophys. Acta 1260:55–61.
  • Hata, S., T. Tsukamoto, and J. Osumi 1992. A novel isoform of rat hepatocyte nuclear factor 4 (HNF-4). Biochim. Biophys. Acta 1131:211–213.
  • Hayashi, Y., S. Ohmori, T. Ito, and J. Seo 1997. A splicing variant of steroid receptor coactivator-1 (SRC-1E): the major isoform of SRC-1 to mediate thyroid hormone action. Biochem. Biophys. Res. Commun. 236:83–87.
  • Heery, D. M., E. Kalkhoven, S. Hoare, and J. Parker 1997. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387:733–736.
  • Hertz, R., J. Magenheim, I. Berman, and J. Bar 1998. Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4alpha. Nature 392:512–516.
  • Hodin, R. A., M. A. Lazar, and J. Chin 1990. Differential and tissue-specific regulation of the multiple rat c-erbA messenger RNA species by thyroid hormone. J. Clin. Investig. 85:101–105.
  • Holewa, B., D. Zapp, T. Drewes, S. Senkel, and J. Ryffel 1997. HNF4β, a new gene of the HNF4 family with distinct activation and expression profiles in oogenesis and embryogenesis of Xenopus laevis. Mol. Cell. Biol. 17:687–694.
  • Hollenberg, A. N., T. Monden, J. P. Madura, K. Lee, and J. Wondisford 1996. Function of nuclear co-repressor protein on thyroid hormone response elements is regulated by the receptor A/B domain. J. Biol. Chem. 271:28516–28520.
  • Hong, H., K. Kohli, M. J. Garabedian, and J. Stallcup 1997. GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Mol. Cell. Biol. 17:2735–2744.
  • Hong, H., K. Kohli, A. Trivedi, D. L. Johnson, and J. Stallcup 1996. GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors. Proc. Natl. Acad. Sci. USA 93:4948–4952.
  • Imhof, A., X. J. Yang, V. V. Ogryzko, Y. Nakatani, A. P. Wolffe, and J. Ge 1997. Acetylation of general transcription factors by histone acetyltransferases. Curr. Biol. 7:689–692.
  • Iyemere, V., N. Davies, and J. Brownlee 1998. The activation function 2 domain of hepatic nuclear factor 4 is regulated by a short C-terminal proline-rich repressor domain. Nucleic Acids Res. 26:2098–2104.
  • Janknecht, R., and J. Hunter 1996. Versatile molecular glue. Transcriptional control. Curr. Biol. 6:951–954.
  • Jenster, G., H. A. G. M. van der Korput, C. van Vroonhoven, T. H. van der Kwast, J. Trapman, and J. Brinkmann 1991. Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization. Mol. Endocrinol. 5:1396–1404.
  • Jeyakumar, M., M. R. Tanen, and J. Bagchi 1997. Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor. Mol. Endocrinol. 11:755–767.
  • Jiang, G., L. Nepomuceno, K. Hopkins, and J. Sladek 1995. Exclusive homodimerization of orphan receptor hepatocyte nuclear factor 4 defines a new subclass of nuclear receptors. Mol. Cell. Biol. 15:5131–5143.
  • Jiang, G., L. Nepomuceno, Q. Yang, and J. Sladek 1997. Serine/threonine phosphorylation of orphan receptor hepatocyte nuclear factor 4. Arch. Biochem. Biophys. 340:1–9.
  • Jiang, G., and J. Sladek 1997. The DNA binding domain of hepatocyte nuclear factor 4 mediates cooperative, specific binding to DNA and heterodimerization with the retinoid X receptor α. J. Biol. Chem. 272:1218–1225.
  • Kalkhoven, E., J. E. Valentine, D. M. Heery, and J. Parker 1998. Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor. EMBO J. 17:232–243.
  • Kamei, Y., L. Xu, T. Heinzel, J. Torchia, R. Kurokawa, B. Gloss, S. C. Lin, R. A. Heyman, D. W. Rose, C. K. Glass, and J. Rosenfeld 1996. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403–414.
  • Klotzbucher, M., C. Schwerk, B. Holewa, and J. Klein 1997. Activation of transcription by progesterone receptor involves derepression of activation functions by a cofactor. Mol. Endocrinol. 11:768–778.
  • Kritis, A. A., A. Argyrokastritis, N. K. Moschonas, S. Power, N. Katrakili, V. I. Zannis, S. Cereghini, and J. Talianidis 1996. Isolation and characterization of a third isoform of human hepatocyte nuclear factor 4. Gene 173:275–280.
  • Ktistaki, E., and J. Talianidis 1997. Chicken ovalbumin upstream promoter transcription factors act as auxiliary cofactors for hepatocyte nuclear factor 4 and enhance hepatic gene expression. Mol. Cell. Biol. 17:2790–2797.
  • Lanz, R. B., and J. Rusconi 1994. A conserved carboxy-terminal subdomain is important for ligand interpretation and transactivation by nuclear receptors. Endocrinology 135:2183–2195.
  • Lazennec, G., T. R. Ediger, L. N. Petz, A. M. Nardulli, and J. Katzenellenbogen 1997. Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: correlations with DNA and coregulator interactions and receptor conformational changes. Mol. Endocrinol. 11:1375–1386.
  • Lin, B. C., S. H. Hong, S. Krig, S. M. Yoh, and J. Privalsky 1997. A conformational switch in nuclear hormone receptors is involved in coupling hormone binding to corepressor release. Mol. Cell. Biol. 17:6131–6138.
  • Lindner, T., C. Gragnoli, H. Furuta, B. N. Cockburn, C. Petzold, H. Rietzsch, U. Weiss, J. Schulze, and J. Bell 1997. Hepatic function in a family with a nonsense mutation (R154X) in the hepatocyte nuclear factor-4alpha/MODY1 gene. J. Clin. Investig. 100:1400–1405.
  • Ma, H., H. Hong, S. Huang, R. A. Irvine, P. Webb, P. J. Kushner, G. A. Coetzee, and J. Stallcup 1999. Multiple signal input and output domains of the 160-kDa nuclear receptor coactivator proteins. Mol. Cell. Biol. 19:6164–6173.
  • Malik, S., and J. Karathanasis 1996. TFIIB-directed transcriptional activation by the orphan nuclear receptor hepatocyte nuclear factor 4. Mol. Cell. Biol. 16:1824–1831.
  • Mangelsdorf, D., and J. Evans 1995. The RXR heterodimers and orphan receptors. Cell 83:841–850.
  • Mangelsdorf, D. J., C. Thummel, M. Beato, P. Herrlich, G. Schutz, K. Umesono, B. Blumberg, P. Kastner, M. Mark, P. Chambon, and J. Evans 1995. The nuclear receptor superfamily: the second decade. Cell 83:835–839.
  • Masuyama, H., C. M. Brownfield, R. St-Arnaud, and J. MacDonald 1997. Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction. Mol. Endocrinol. 11:1507–1517.
  • Michael, L. F., M. A. Lazar, and J. Mendelson 1997. Peroxisome proliferator-activated receptor gammal expression is induced during cyclic adenosine monophosphate-stimulated differentiation of alveolar type II pneumonocytes. Endocrinology 138:3695–3703.
  • Moller, A. M., S. A. Urhammer, L. T. Dalgaard, R. Reneland, L. Berglund, T. Hansen, J. O. Clausen, H. Lithell, and J. Pedersen 1997. Studies of the genetic variability of the coding region of the hepatocyte nuclear factor-4alpha in Caucasians with maturity onset NIDDM. Diabetologia 40:980–983.
  • Montano, M. M., V. Muller, A. Trobaugh, and J. Katzenellenbogen 1995. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists. Mol. Endocrinol. 9:814–825.
  • Muraoka, R. S., S. E. Waltz, and J. Degen 1999. Expression of hepatocyte growth factor-like protein is repressed by retinoic acid and enhanced by cyclic adenosine 3′,5′-monophosphate response element-binding protein (CREB)-binding protein (CBP). Endocrinology 140:187–196.
  • Nakhei, H., A. Lingott, I. Lemm, and J. Ryffel 1998. An alternative splice variant of the tissue specific transcription factor HNF4alpha predominates in undifferentiated murine cell types. Nucleic Acids Res. 26:497–504.
  • Nolte, R. T., G. B. Wisely, S. Westin, J. E. Cobb, M. H. Lambert, R. Kurokawa, M. G. Rosenfeld, T. M. Willson, C. K. Glass, and J. Milburn 1998. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature 395:137–143.
  • Onate, S. A., V. Boonyaratanakornkit, T. E. Spencer, S. Y. Tsai, M. J. Tsai, D. P. Edwards, and J. O’Malley 1998. The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptors. J. Biol. Chem. 273:12101–12108.
  • Onate, S. A., S. Y. Tsai, M.-J. Tsai, and J. O’Malley 1995. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354–1357.
  • Pemrick, S. M., D. A. Lucas, and J. Grippo 1994. The retinoid receptors. Leukemia 8:1797–1806.
  • Perlmann, T., and J. Evans 1997. Nuclear receptors in Sicily. Cell 90:391–397 (Meeting review.)
  • Raney, A. K., J. L. Johnson, C. N. Palmer, and J. McLachlan 1997. Members of the nuclear receptor superfamily regulate transcription from the hepatitis B virus nucleocapsid promoter. J. Virol. 71:1058–1071.
  • Reijnen, M. J., F. M. Sladek, R. M. Bertina, and J. Reitsma 1992. Disruption of a binding site for hepatocyte nuclear factor 4 results in hemophilia B. Leyden. Proc. Natl. Acad. Sci. USA 89:6300–6303.
  • Renaud, J., N. Rochel, M. Ruff, V. Vivat, P. Chambon, H. Gronemeyer, and J. Moras 1995. Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid. Nature 378:681–689.
  • Rosen, C. A., J. G. Sodroski, and J. Haseltine 1985. The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat. Cell 41:813–823.
  • Rottman, J. N., R. L. Widom, B. Nadal-Ginard, V. Mahdavi, and J. Karathanasis 1991. A retinoic acid-responsive element in the apolipoprotein AI gene distinguishes between two different retinoic acid response pathways. Mol. Cell. Biol. 11:3814–3820.
  • Sande, S., and J. Privalsky 1996. Identification of TRACs (T3 receptor-associating cofactors), a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors. Mol. Endocrinol. 10:813–825.
  • Shibata, H., T. E. Spencer, S. A. Onate, G. Jenster, S. Y. Tsai, M. J. Tsai, and J. O’Malley 1997. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. Recent Prog. Horm. Res. 52:141–164.
  • Sladek, F., Q. Dallas-Yang, and J. Nepomuceno 1998. MODY1 mutation Q268X in hepatocyte nuclear factor 4α allows for dimerization in solution but causes abnormal subcellular localization. Diabetes 47:985–990.
  • Sladek, F. M. 1994. Hepatocyte nuclear factor 4 (HNF-4), p. 207–230. In F. Tronche, M. Yaniv (ed.), Liver gene expression. R. G. Landes Co., Austin, Tex.
  • Sladek, F. M., W. Zhong, E. Lai, and J. Darnell 1990. Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev. 4:2353–2365.
  • Smith, C. W. J., J. G. Patton, and J. Nadal-Ginard 1989. Alternative splicing in the control of gene expression. Annu. Rev. Genet. 23:527–577.
  • Tate, B. F., G. Allenby, J. R. Perez, A. A. Levin, and J. Grippo 1996. A systematic analysis of the AF-2 domain of human retinoic acid receptor alpha reveals amino acids critical for transcriptional activation and conformational integrity. FASEB J. 10:1524–1531.
  • Torchia, J., C. Glass, and J. Rosenfeld 1998. Co-activators and co-repressors in the integration of transcriptional responses. Curr. Opin. Cell Biol. 10:373–383.
  • Torchia, J., D. W. Rose, J. Inostroza, Y. Kamei, S. Westin, C. K. Glass, and J. Rosenfeld 1997. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387:677–684.
  • Voegel, J. J., M. J. Heine, M. Tini, V. Vivat, P. Chambon, and J. Gronemeyer 1998. The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways. EMBO J. 17:507–519.
  • Voegel, J. J., M. J. Heine, C. Zechel, P. Chambon, and J. Gronemeyer 1996. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J. 15:3667–3675.
  • Wang, J. C., J. M. Stafford, and J. Granner 1998. SRC-1 and GRIP1 coactivate transcription with hepatocyte nuclear factor 4. J. Biol. Chem. 273:30847–30850.
  • Webb, P., P. Nguyen, J. Shinsako, C. Anderson, W. Feng, M. P. Nguyen, D. Chen, S. M. Huang, S. Subramanian, E. McKinerney, B. S. Katzenellenbogen, M. R. Stallcup, and J. Kushner 1998. Estrogen receptor activation function 1 works by binding p160 coactivator proteins. Mol. Endocrinol. 12:1605–1618.
  • Westin, S., R. Kurokawa, R. T. Nolte, G. B. Wisely, E. M. McInerney, D. W. Rose, M. V. Milburn, M. G. Rosenfeld, and J. Glass 1998. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators. Nature 395:199–202.
  • Williams, S. P., and J. Sigler 1998. Atomic structure of progesterone complexed with its receptor. Nature 393:392–396.
  • Xu, J., Z. Nawaz, S. Y. Tsai, M. J. Tsai, and J. O’Malley 1996. The extreme C terminus of progesterone receptor contains a transcriptional repressor domain that functions through a putative corepressor. Proc. Natl. Acad. Sci. USA 93:12195–12199.
  • Xu, L., C. K. Glass, and J. Rosenfeld 1999. Coactivator and corepressor complexes in nuclear receptor function. Curr. Opin. Genet. Dev. 9:140–147.
  • Yamagata, K., H. Furuta, N. Oda, P. J. Kaisaki, S. Menzel, N. J. Cox, S. S. Fajans, S. Signorini, M. Stoffel, and J. Bell 1996. Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1). Nature 384:458–460.
  • Yoshida, E., S. Aratani, H. Itou, M. Miyagishi, M. Takiguchi, T. Osumu, K. Murakami, and J. Fukamizu 1997. Functional association between CBP and HNF4 in trans-activation. Biochem. Biophys. Res. Commun. 241:664–669.
  • Zhang, S., X. Liang, and J. Danielsen 1996. Role of the C terminus of the glucocorticoid receptor in hormone binding and agonist/antagonist discrimination. Mol. Endocrinol. 10:24–34.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.